Incyte Genomics (INCY) Misses Q2 Views
Tweet
Share
E-mailGet Alerts INCY Hot Sheet
Price: $124.65 --0%
Revenue Growth %: +7.3%
Financial Fact:
Basic (in dollars per share): 0.2
Today's EPS Names:
OCCI, ALZN, ASPU, More
Revenue Growth %: +7.3%
Financial Fact:
Basic (in dollars per share): 0.2
Today's EPS Names:
OCCI, ALZN, ASPU, More
Join SI Premium – FREE
Incyte Genomics (NASDAQ: INCY) reported Q2 EPS of ($0.41), $0.05 worse than the analyst estimate of ($0.36). Revenue for the quarter came in at $16.8 million versus the consensus estimate of $19.17 million.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Incyte (INCY) Reiterated at Neutral by Cantor Fitzgerald as Opzelura Attractive in HS
- Ennis (EBF) Misses Q2 EPS by 2c
- Radiant Logistics (RLGT) Tops Q4 EPS by 9c
Create E-mail Alert Related Categories
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
